Correlation Between Expression of SIX1, TGF-β and VEGF-C in Primarily Cultured Human Laryngeal Squamous Cell Carcinoma Cells
-
摘要:目的
探讨原代人喉鳞癌细胞中SIX1、TGF-β、VEGF-C表达相关性。
方法取新鲜人喉鳞状细胞癌组织，进行原代细胞培养，利用基因干扰技术，制备SIX1、TGF-β及SIX1+TGF-β靶向siRNA转染至人喉鳞癌细胞，转染成功后将实验细胞分为5组： A组（未转染组）、B组（转染空载体组）、C组（SIX1-siRNA组）、D组（TGFβ-siRNA组）、E组（SIX1+TGF-β-siRNA组）。Western blot及细胞爬片免疫荧光检测各组细胞SIX1、TGF-β及VEGF-C蛋白的表达。RT-PCR检测各组细胞SIX1、TGF-β及VEGF-C mRNA的表达。
结果SIX1、TGF-β、VEGF-C蛋白及其mRNA的表达在未转染组、转染空载体组中差异无统计学意义。同未转染组相比，SIX1蛋白及其mRNA的表达在SIX1-siRNA组降低的同时出现了VEGF-C表达的降低；TGF-β蛋白及其mRNA的表达在TGFβ-siRNA组降低的同时也出现了VEGF-C表达的降低，差异均有统计学意义。同SIX1-siRNA组、 TGFβ-siRNA组相比，VEGF-C蛋白及其mRNA的表达在SIX1+TGF-β-siRNA组未出现进一步降低。
结论SIX1和TGF-β能够共同作用促进VEGF-C蛋白及其 mRNA的表达，进而促进人喉鳞癌的淋巴转移。SIX1、TGF-β的变化可能成为临床抑制人喉鳞癌淋巴结转移的潜在靶点。
Abstract:ObjectiveTo investigate the relationship between sine oculis homeobox homolog 1(SIX1) , TGF-β and VEGF-C in primarily cultured human laryngeal squamous cell carcinoma cells.
MethodsWe took fresh human laryngeal squamous cell carcinoma tissues and cultured the primary cells. The technology of RNA interference was used for preparing SIX1-targeting, TGF-β-targeting and SIX1+TGF-β-targeting siRNA to transfect laryngeal squamous cell carcinoma cells. After successful transfection, the experiments were divided into five groups: Group A (untransfected), Group B(empty vector), Group C(SIX1-siRNA), Group D(TGF-β-siRNA) and Group E(SIX1+TGF-β-siRNA). The protein expression of SIX1, TGF-β and VEGF-C were determined by immunohistochemistry and Western blot. The mRNA levels of SIX1, TGF-β and VEGF-C were determined by RT-PCR.
ResultsThe protein and mRNA expression of SIX1, TGF-β and VEGF-C in empty vector group had no significant difference compared with untransfected group. In SIX1- siRNA group, the expression of SIX1 protein and mRNA were decreased, at the same time the expression of VEGF-C was decreased, with statistically significant difference compared with untransfected group. In TGF- β-siRNA group, the expression of TGF-β protein and mRNA were decreased, at the same time the expression of VEGF-C was decreased, with statistically significant difference compared with untransfected group. Compared with SIX1-siRNA and TGF-β-siRNA groups, the expression of VEGF-C protein and mRNA had no significant decrease in SIX1+TGF-β-siRNA group.
ConclusionSIX1 could promote lymph node metastasis by coordinating with TGF-β to increase the expression of VEGF-C protein and mRNA, suggesting that SIX1 and TGF-β might be potential therapeutic targets for preventing lymph node metastasis from human laryngeal squamous cell carcinoma.
-
Key words:
- SIX1 /
- TGF-β /
- VEGF-C /
- Primary human laryngeal squamous cell carcinoma cells
-
-
![]()
图 1 人喉鳞癌细胞中SIX1、TGF-β和VEGF-C蛋白表达 (×200)
Figure 1 Expressions of SIX1, TGF-β and VEGF-C proteins in human laryngeal squamous cell carcinoma cells (×200)
![]()
图 2 人喉鳞癌细胞中SIX1、TGF-β和VEGF-C mRNA的表达
Figure 2 Expressions of SIX1, TGF-β and VEGF-C mRNA in human laryngeal squamous cell
表 1 Western blot结果显示各试验组SIX1、TGF-β和VEGF-C蛋白表达
Table 1 Expressions of SIX1, TGF-β and VEGF-C proteins in human laryngeal squamous cell carcinoma cells in each experimental groups detected by Western blot
下载: 导出CSV
-
[1] Zhu H, Yun F, Shi X, et al. VEGF C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin[J].Mol Med Rep, 2015, 12(2) : 3163-9.
[1] Zhu H, Yun F, Shi X, et al. VEGF C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin[J]. Mol Med Rep, 2015, 12(2): 3163-9. [2] Zhao T, Zhao W, Meng W, et al. VEGF-C/VEGFR-3 pathway promotes myocyte hypertrophy and survival in the infarcted myocardium[J]. Am J Transl Res, 2015, 7(4) : 697-709.
[2] Zhao T, Zhao W, Meng W, et al. VEGF-C/VEGFR-3 pathway promotes myocyte hypertrophy and survival in the infarcted myocardium[J]. Am J Transl Res, 2015, 7(4): 697-709. [3] 夏现印, 王秀梅. 转化生长因子-β1在肿瘤中的研究进展[J]. 现代肿瘤医学, 2014, 22(3) : 710-3. Xia XY, Wang XM. Progression of transforming growth factor-β1 in tumor[J]. Xian Dai Zhong Liu Yi Xue, 2014, 22(3) : 710-3.
[3] Xia XY, Wang XM. Progression of transforming growth factor-β1 in tumor[J]. Xian Dai Zhong Liu Yi Xue, 2014, 22(3): 710-3. [夏 现印, 王秀梅. 转化生长因子-β1在肿瘤中的研究进展[J]. 现代 肿瘤医学, 2014, 22(3): 710-3.] [4] 马建波, 戴金华, 余秋云, 等. 非小细胞肺癌患者血清TGF-β1检测水平的临床研究[J].中国卫生检验杂志, 2010, 20(6) : 1456-7. Ma JB, Dai JH, Yu QY, et al. Clinical study on levels of serum TGF-β1 in non-small cell lung cancer[J]. Zhongguo Wei Sheng Jian Yan Za Zhi, 2010, 20(6) : 1456-7.
[4] Ma JB, Dai JH, Yu QY, et al. Clinical study on levels of serum TGF-β1 in non-small cell lung cancer[J]. Zhongguo Wei Sheng Jian Yan Za Zhi, 2010, 20(6): 1456-7. [马建波, 戴金华, 余秋云, 等. 非小细胞肺癌患者血清TGF-β1检测水平的临床研究[J].中 国卫生检验杂志, 2010, 20(6): 1456-7.] [5] 李晓勇, 刘少平. 结直肠癌患者血清 TGF-β1的检测及临床意义[J]. 广西医科大学学报, 2011, 28(1) : 82-4. Li XY, Liu SP. Clinical significance of TGF- detection in the serum of patients with colorectal cancer[J]. Guangxi Yi Ke Da Xue Xue Bao, 2011, 28(1) : 82-4.
[5] Li XY, Liu SP. Clinical significance of TGF- detection in the serum of patients with colorectal cancer[J]. Guangxi Yi Ke Da Xue Xue Bao, 2011, 28(1): 82-4. [李晓勇, 刘少平. 结直肠癌患者血清 TGF-β1的检测及临床意义[J]. 广西医科大学学报, 2011, 28(1): 82 -4.] [6] 张梁, 黄涵, 黄永秩, 等. TGF-β1和Smad4在大肠癌中的表达及其临床意义[J]. 右江医学, 2010, 38(1) : 10-1. Zhang L, Huang H, Huang YZ, et al. Expression and clinical significance of TGF-β1 and Smad4 in colorectal carcinoma[J]. Youjiang Yi Xue, 2010, 38(1) : 10-1.
[6] Zhang L, Huang H, Huang YZ, et al. Expression and clinical significance of TGF-β1 and Smad4 in colorectal carcinoma[J]. Youjiang Yi Xue, 2010, 38(1): 10-1. [张梁, 黄涵, 黄永秩, 等. TGF-β1和Smad4在大肠癌中的表达及其临床意义[J]. 右江医 学, 2010, 38(1): 10-1.] [7] Dhasarathy A, Phadke D, Mav D, et al. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer[J]. PLoS One, 2011, 6(10) : 265-9.
[7] Dhasarathy A, Phadke D, Mav D, et al. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer[J]. PLoS One, 2011, 6(10): 26 5-9. [8] Sun FD, Zhang JZ, Cui Y, et al. Expressions of TGFβ1/Smads proteins in breast cancer tissues and their clinical significance[J]. Jilin Da Xue Xue Bao(Yi Xue Ban), 2012, 38(1): 93-7. [孙凤丹,张金子, 崔演, 等. TGFβ1/Smads信号通路相关蛋白在乳腺癌 组织中的表达及其临床意义[J]. 吉林大学学报(医学版), 2012, 38 (1): 93-7.] [8] 孙凤丹, 张金子, 崔演, 等. TGFβ1/Smads信号通路相关蛋白在乳腺癌组织中的表达及其临床意义[J]. 吉林大学学报(医学版), 2012, 38(1) : 93-7. Sun FD, Zhang JZ, Cui Y, et al. Expressions of TGFβ1/Smads proteins in breast cancer tissues and their clinical significance[J]. Jilin Da Xue Xue Bao(Yi Xue Ban), 2012, 38(1) : 93-7.
[9] Suzuki Y, Ito Y, Mizuno M, et al. Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction[J]. Kidney Int, 2012, 81(9) : 865-79.
[9] Suzuki Y, Ito Y, Mizuno M, et al. Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction[J]. Kidney Int, 2012, 81(9): 865-79. [10] Oka M, Iwata C, Suzuki HI, et al. Inhibition of endogenous TGFbeta signaling enhances lymphangiogenesis[J]. Blood, 2008, 11 1(9): 4571-9. [10] Oka M, Iwata C, Suzuki HI, et al. Inhibition of endogenous TGFbeta signaling enhances lymphangiogenesis[J]. Blood, 2008, 111(9) : 4571-9.
[11] Clavin NW, Avraham T, Fernandez J, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair[J]. Am J Physiol Heart Circ Physiol, 2008, 295(5) : H2113-27.
[11] Clavin NW, Avraham T, Fernandez J, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair[J]. Am J Physiol Heart Circ Physiol, 2008, 295(5): H2113-27. [12] Jin H, Cui M, Kong J, et al. Sineoculis homeobox homolog 1 protein is associated with breast cancer progression and survival outcome[J]. Exp Mol Pathol, 2014, 97(2) : 247-52.
[12] Jin H, Cui M, Kong J, et al. Sineoculis homeobox homolog 1 protein is associated with breast cancer progression and survival outcome[J]. Exp Mol Pathol, 2014, 97(2): 247-52. [13] Qamar L, Deitsch E, Patrick AN, et al. Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer[J]. Gynecol Oncol, 2012, 125(2) : 451-7.
[13] Qamar L, Deitsch E, Patrick AN, et al. Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer[J]. Gynecol Oncol, 2012, 125(2): 451-7. [14] Kong J, Zhou X, Liu S, et al. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(6): 3018-27. [14] Kong J, Zhou X, Liu S, et al. Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma[J]. Int J Clin Exp Pathol, 2014, 7(6) : 3018-27.
[15] Liu D, Li L, Zhang XX, et al. SIX1 promotes tumor lymphangiogenesis by coordinating TGF-β signals that increase expression of VEGF-C[J]. Cancer Res, 2014, 74(19): 5597-607. [15] Liu D, Li L, Zhang XX, et al. SIX1 promotes tumor lymphangiogenesis by coordinating TGF-β signals that increase expression of VEGF-C[J]. Cancer Res, 2014, 74(19) : 5597-607.
[16] Wang CA, Jedlicka P, Patrick AN, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer[J]. J Clin Invest, 2012, 122(5) : 1895-906.
[16] Wang CA, Jedlicka P, Patrick AN, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer[J]. J Clin Invest, 2012, 122(5): 18 95-906. [17] Gaspar NJ, Li L, Kapoun AM, et al. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness[J]. Mol Pharmacol, 2007, 72(1): 152-61. [17] Gaspar NJ, Li L, Kapoun AM, et al. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness[J]. Mol Pharmacol, 2007, 72(1) : 152-61.
计量
- 文章访问数: 1150
- HTML全文浏览量: 338
- PDF下载量: 209
